As of December 31, 2023, 26 pharmaceutical companies have been rated as "especially serious" and "serious" breach of trust. The pharmaceutical price and procurement credit evaluation system divides corporate dishonesty into four levels.
Those who reach a certain level will be suspended from online purchasing qualifications. The prices and business behaviors of enterprises in the pharmaceutical market must abide by the fair and legal, honest and trustworthy market, and the quality and price are consistent, according to the rules. In the end, it is the medical insurance and the people who bear the undue burden.